Zacks Investment Research on MSN
Strength seen in Korro Bio, Inc. (KRRO): Can its 13.9% jump turn into more strength?
Korro Bio, Inc. (KRRO) shares soared 13.9% in the last trading session to close at $13.31. The move was backed by solid ...
Zacks Investment Research on MSN
What makes Cabaletta Bio, Inc. (CABA) a strong momentum stock: Buy now?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long ...
Nuvation Bio Inc. (NYSE:NUVB) is one of the Best Small Cap Stocks Ready to Explode in 2026. On January 27, Gregory Renza ...
TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation ...
New capabilities mark continued momentum as company advances discovery research applications and accelerates the global growth of its spatial biology business Takara Bio USA, Inc. (“Takara Bio USA”), ...
INmune Bio Inc. (NASDAQ:INMB) stock surged by 24.72% in after-hours trading on Friday. The company announced a novel selective soluble TNF inhibitor, which is likely to have influenced the stock’s ...
Qlaris Bio, Inc., a clinical-stage biotechnology company focused on developing first-in-class therapies for glaucoma, today announced the appointment of Robert Warner to its board of directors. Mr.
Climb Bio, Inc., a clinical-stage biotechnology company focused on therapies for immune-mediated diseases, has announced the appointments of Dr. Edgar D. Charles as Chief Medical Officer and Cindy J.
Climb Bio appointed Dr. Perrin Wilson as Chief Business Officer to strengthen its leadership in developing immune-mediated disease treatments. Climb Bio, Inc. has announced the appointment of Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results